Clinical research of qingkailing soft capsules in treating acute upper respiratory infection.
- Author:
Chun-sheng LI
1
;
Jie LI
;
Xiu-zhen WANG
;
Xian-chun WANG
;
Xian-yi LIN
;
Shao-neng LIU
;
Xu-dong TANG
;
Wei-ping KONG
;
Shu WANG
;
Yan-zhong SHANG
;
Jin FAN
;
Shu-yi ZHENG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Capsules; Drug Combinations; Drugs, Chinese Herbal; isolation & purification; therapeutic use; Female; Humans; Leukocyte Count; Male; Materia Medica; isolation & purification; therapeutic use; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Plants, Medicinal; chemistry; Respiratory Tract Infections; drug therapy
- From: China Journal of Chinese Materia Medica 2005;30(21):1692-1695
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo discuss the efficacy of Qingkailing soft capsules in treating acute fever, and the relationship between symptoms-effect and time effect.
METHODQingkailing soft capsules was taken orally, 4 times a day, 1.6 g each time. Shuanghuanglian kou fu liquid was taken as control. 129 patients with acute upper respiratory tract infection were recruited.
RESULTThere were 73.34% of patients cured by Qingkailing soft capsules and 43.59% cured by Shuanghuanglian kou fu liquid. The efficacy of the former was better than that of the latter (P < 0.05). The efficacy of Qingkailing soft capsules in treating Fengrexing was better than that in Fenghanxing (P < 0.05). The efficacy of Qingkailing soft capsules in reducing rapid pulse and adding moderate pulse was more remarkable than Shuanghuanglian kou fu liquid (P < 0.05). Taking Qingkailing soft capsules seldom induced mild gastrointestinal disturbance.
CONCLUSIONQingkailing soft capsules showed good result in the treatment of acute upper respiratory tract infection with less adverse effect.
